Malignant neoplasm of carotid body
ICD-10 C75.4 is a billable code used to indicate a diagnosis of malignant neoplasm of carotid body.
The carotid body is a small cluster of chemoreceptors and supporting cells located at the bifurcation of the common carotid artery. It plays a crucial role in the regulation of respiratory and cardiovascular functions by detecting changes in blood oxygen, carbon dioxide, and pH levels. A malignant neoplasm of the carotid body, classified under ICD-10 code C75.4, is a rare tumor that arises from the paraganglionic tissue of the carotid body. These tumors are typically slow-growing and may be asymptomatic in the early stages. Symptoms, when present, can include neck swelling, pain, or neurological deficits due to local invasion or compression of adjacent structures. The diagnosis is often confirmed through imaging studies such as CT or MRI, and histopathological examination following biopsy. Treatment usually involves surgical excision, and in some cases, radiation therapy may be indicated. Due to its endocrine nature, the tumor may also influence hormone levels, leading to metabolic changes that require careful monitoring and management.
Detailed pathology reports, imaging studies, and treatment plans must be documented.
Diagnosis and management of carotid body tumors, including surgical interventions.
Ensure accurate staging and grading of the tumor for appropriate coding.
Hormonal assessment results and metabolic evaluations should be included.
Management of metabolic changes due to hormone secretion from the tumor.
Monitor for potential endocrine dysfunction and document any related symptoms.
Used in conjunction with surgical excision of the tumor.
Document the indication for lymphatic mapping and the findings.
Oncology specialists should ensure accurate coding of the procedure.
Common symptoms include neck swelling, pain, and neurological deficits due to local invasion. Some patients may also experience symptoms related to hormonal secretion, such as hypertension.
